•
Jun 30, 2021

Anaptysbio Q2 2021 Earnings Report

Total Revenue
$30M
EPS
-$0.02
Previous year: -$0.79
-97.5%
Gross Profit
$4.71M
Cash and Equivalents
$332M
Previous year: $221M
+50.2%
Free Cash Flow
$8.73M
Previous year: -$19.7M
-144.3%
Total Assets
$427M
Previous year: $402M
+6.2%

Anaptysbio

Anaptysbio